Pfizer expects $15 billion in sales from COVId-19 Vaccine in 2021

Advertisement

Pfizer Inc. issued a statement claiming that the pharmaceutical giant and one of the biggest supplier & manufacturer of COVID-19 vaccine expects around $15 billion from it’s sales.

In 2021 the company expects to generate total revenue around $61.4 billion if not less.

Pfizer currently manufacture Corona-virus vaccine in association with German partner BioNTech and was one of the first vaccine to receive emergency use approval from US and many other countries around the globe.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More